IHCVIsrael Healthcare Ventures
References in periodicals archive ?
This successful financing is a direct result of NiTi Surgical Solutions' well-executed business strategy and growing market presence in anastomosis, with its proprietary BioDynamix Technology," stated Hadar Ron, MD, managing director of IHCV and chairman of the Board of Directors for NiTi.
Current shareholders include Elbit Imaging, Biomedical Investments, IHCV, Teva Pharmaceutical Industries (NASDAQ: TEVA), Denali Ventures, and Auriga Ventures.
I have also decided to increase my investment in the Company through IHCV, because I believe that their unique non-invasive monitoring systems address major unmet medical needs and represent a potential for rapid market acceptance and profitability," stated Mr.